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Good communication is essential between patients diagnosed with cancer and their physician. 
Norwegian patients have a legal right to participate in shared decision making (SDM), and 
they must be provided sufficient information to meet their individual needs.  
 
Communication aids can assist patients in obtaining the necessary information about their 
disease and treatment options. In this study, we explored the effect of two such 
communication aids: A question prompt list (QPL) and a consultation audio record (CAR) for 
the patients to bring home. 
 
A QPL is a list of suggested questions patients might want to ask their doctor. The Australian 
QPL “So you have cancer” was translated into Norwegian, and then culturally adjusted after 
feedback from focus groups consisting of Norwegian cancer patients, as well as a survey.  
Minimal changes were required to the wording of the original questions; however, focus 
groups identified three subjects to be added: Accompanying relatives, children as next of kin 
and rehabilitation. Most questions of the original QPL were considered useful by survey 
respondents, with only three questions omitted as they were not deemed useful. 
 
The QPL was provided to patients as part of an explorative study, either alone or in 
combination with a CAR. Results from these intervention groups were compared to a 
previous control group. Audio files of the consultations from the control group were subject to 
analysis on questions and emotional cues and concerns, and their relation to physician SDM 
behavior. While such a relationship was not detected, our study found that patients with a high 
level of anxiety asked more questions and expressed a higher amount of emotional cues or 
concerns. The majority of questions asked by the control group related to treatment and 
practical issues. Few questions were raised about prognosis and treatment options, which are 
deemed essential for patients to participate in SDM. 
 
Patients that were provided a QPL asked significantly more questions about their prognosis, 
the disease and the quality of treatment. The study did not find any relationship between the 
provision of a QPL and physician SDM, nor did it find any difference in the level of anxiety, 
depression and quality of life between the patients who were provided a QPL alone, a 
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combined QPL and CAR, or the control group. Providing patients with the QPL increased the 
consultation length significantly. However, patients rated both the QPL and the CAR 
positively. 
 
In this thesis, we culturally adapted a QPL to a Norwegian setting and explored the effect of 
the QPL alone and in combination with a CAR.  While our research has shed light on 
Norwegian cancer patients’ information need, we could not determine any effect of patients’ 




God kommunikasjon er essensielt i møte mellom pasient og lege i kreftomsorgen. I Norge har 
pasienter en lovfestet rett til å medvirke i beslutninger som gjelder egen helse (samvalg) og 
sentralt i dette står god informasjon tilpasset den enkelte pasients behov. 
Kommunikasjonshjelpemidler kan bidra til at pasienter får den informasjonen de ønsker om 
blant annet kreftsykdommen og behandlingsmuligheter. I denne studien har vi undersøkt 
effekten av to kommunikasjonshjelpemidler: En spørsmålsliste som på engelsk går under 
navnet «question prompt list» og lydopptak av konsultasjon, som pasienten får med hjem. 
En spørsmålsliste er en liste med forslag til spørsmål pasienter kan ønske å spørre 
behandlende lege om. I denne studien har vi oversatt en eksisterende australsk spørsmålsliste 
og tilpasset den norske forhold. Dette har vi gjort gjennom litteratursøk, fokusgrupper og en 
spørreundersøkelse blant erfarne norske kreftpasienter. Prosessen ført til minimale endringer i 
ordlyd av spørsmål. I fokusgruppene kom det imidlertid frem tre tema som manglet og som 
senere ble formulert som nye spørsmål: Å ta pårørende med til konsultasjon, barn som 
pårørende og rehabilitering. I spørreundersøkelsen ble mange av spørsmålene i den 
opprinnelige listen vurdert å være nyttige for norske kreftpasienter, men tre spørsmål ble 
vurdert som mindre nyttige og ble dermed fjernet. 
Vi utførte deretter en intervensjonsstudie der vi undersøkte bruken av spørsmålslista, også i 
kombinasjon med lydopptak av konsultasjonen. Data fra disse gruppene ble sammenliknet 
med en tidligere kontrollgruppe. I kontrollgruppa gjorde vi utvidede analyser der vi 
undersøkte om det var en sammenheng mellom antall spørsmål og emosjonelle 
hint/bekymringer fra pasienten og grad av samvalg. En slik sammenheng fant vi ikke. 
Derimot fant vi at pasienter som hadde høy angstscore før konsultasjonen stilte flere spørsmål 
og kom med flere emosjonelle hint og bekymringer. Hovedmengden av pasientspørsmål i 
kontrollgruppa omhandlet behandling og praktiske forhold, mens pasientene i liten grad 
spurte om prognose og behandlingsmuligheter, tema som er essensielle for å kunne medvirke 
i samvalg. 
I de gruppene som fikk spørsmålslista fant vi at pasientene spurte signifikant flere spørsmål 
om prognose, sykdommen og kvaliteten på behandlingen. Vi fant derimot ingen effekt av 
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spørsmålslista på samvalg, samtidig som tidsbruken økte. Pasienter vurderte begge 
kommunikasjonshjelpemidlene som nyttige, og vi fant ingen forskjell i anst, depresjon eller 
livskvalitet mellom gruppene som fikk spørsmålslista eller kombinasjon av spørsmålslista og 
lydopptaket, sammenliknet med kontrollgruppa. 
I denne studien har vi tilpasset en Australsk spørsmålsliste til norske forhold og undersøkt 
effekten av denne alene og i kombinasjon med lydopptak av konsultasjonen. Mens vår 
forskning har kastet lys over norske kreftpasienters informasjonsbehov har vi ikke klart å 
finne noen sammenheng mellom pasientenes verbale adferd i konsultasjoner og i hvor stor 
grad leger tar pasienter med på samvalg. 
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1 INTRODUCTION  
The incidence of cancer is steadily increasing in Norway, and a total of 32 827 new cases 
were reported in 2016 [1]. The risk of receiving a cancer diagnosis increases with age, and 
approximately 36 % of men and 30 % of women will be diagnosed with cancer by the age of 
75 years [1]. Despite the continuous development of new treatments, receiving a cancer 
diagnosis can be a life-threatening experience and in 2016 approximately 11 000 deaths were 
reported [2].  
1.1 Clinical communication  
While clinical communication has been present at all times, knowledge of the factors that 
affect effective patient-physician communication has evolved over time. Prior to the last four 
decades, this patient-physician relationship was characterized by a paternalistic approach 
(where the physician decided what was best for the patient), gradually moving towards a more 
patient-centered approach [3]. During this transition, communication has become an essential 
component of the physicians’ role [4].  
Patient centered care aims to provide care that is respectful and responsive to the individual 
patients’ preferences, needs and values, ensuring patient values guide all clinical decisions 
[5]. Patient centered care has evolved due to political influences in society, and is fostered by 
the ethical imperative to share important decisions with patients [6].  
An early study by Kaplan et al. [7] published in 1989 demonstrated that specific aspects of 
patient/physician communication was related to better health, better functional status, and 
better evaluation of overall health status. Moreover, the association between communication 
and health outcomes has been confirmed in later studies [8-10], and specific pathways have 
been proposed to link patient-physician communication to better health outcomes [11]. 
Patient-centered care is now widely endorsed as a central element of high-quality health care 
[12, 13]. In a review article by Robinson et al. [14], the characteristics of patient-centered care 
are identified as patients’ involvement in care and the individualization of patient care. The 
authors further argue that effective patient-centered care is related to communication, shared 
decision making and patient education. 
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A more recent attempt to make a concept analysis of patient-centered care suggests it to be a 
bio-psycho-social approach and attitude, which aims to deliver care that is respectful, 
individualized and empowering [15]. In this paper, the concept “individual patient 
participation” is defined to revolve around patients’ right and opportunity to influence and 
engage in the decision making process through a dialogue concerning patients’ preferences 
and potential and the professionals’ expert knowledge [15]. The authors further argue that by 
focusing on patient participation as a strategy, a patient-centered approach is facilitated, thus 
binding the concepts together. When exploring patients’ perception of the term “patient 
participation”, Eldh et al. [16] identified the main issues to be information exchange and 
sharing respect.  
Considerable amount of information is exchanged in every medical encounter. For cancer 
patients, almost all treatment decisions are made in the first consultation after the patient has 
received a cancer diagnosis [17]. As may be expected, patients’ information need is reported 
to be highest in the time close to receiving the diagnosis [18]. Most patients want truthful 
information about their disease, even if the information is bleak [19]. Patients’ desire to 
receive adequate information has been a consistent finding throughout more than 30 years of 
communication research [20]. A large UK study of 2331 cancer patients revealed that 87% 
wanted as much information as possible and that 98% wanted to know if their diagnosis was 
cancer [19].  
In order to take an active part in consultations, cancer patients have to assimilate complex 
information. Studies show that up to one third of patients misunderstand the information they 
receive from their physicians, and some patients fail to understand if the treatment goal is cure 
or life prolonging [21, 22]. Thus, one of the main challenges that oncologists face is how to 
communicate information in a manner that is responsive to the individual patients’ need, and 
facilitate patient recall and understanding [23].  
Even though most doctors in western countries tell patients their diagnosis of cancer, 
information about prognosis is less commonly provided [24, 25]. This reluctance to discuss 
prognosis is probably caused as much by doctors’ uncertainty about how to present prognosis, 
as it is by patients’ reluctance to ask [26]. There is evidence that cancer patients value 
prognostic information and that discussing life expectancy can reduce anxiety while 
maintaining hope [27-29]. In a study by Hagerty et al. [30], 98 % of patients with incurable 
cancer wanted their doctor to be realistic, provide an opportunity to ask questions and 
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acknowledge them as individuals when discussing prognosis. In this study, almost 70 % of the 
patients would have liked their physician to initiate a discussion about prognosis, while 10% 
did not want information about prognosis at all.  
In a Norwegian study exploring physicians’ attitude towards disclosure of prognostic 
information, 43% of the physicians agreed to the statement “Generally, physicians should 
wait until asked before offering prognostic information” [26]. This study also showed a 
tendency to skew prognostic information in an optimistic direction, and which was more 
common among less experienced physicians. Similarly, in a study by Lamont et al. [31] 
physicians in a US hospice setting reported to provide honest survival estimates only 37% of 
the time when their patients requested them to. This might reduce cancer patients’ ability to 
choose treatments according to their preferences, as evidence has shown that honest 
prognostic estimates can influence treatment preferences [32]. 
Patient and physician communication is commonly extended to include one or more relatives, 
most often spouse or adult children, and less commonly other family and friends [33-36]. The 
term “patient- and family- centered care” incorporates caregivers in the concept of patient-
centered care [37].  
1.2 Emphasis on clinical communication 
There has been an increasing focus on medical communication, and it is now considered an 
important physician skill [38-40]. The effect of poor communication is evident from the 
annual rapport of the Norwegian National Patient  Representative (reviewing patients’ 
complaints), who found that nearly all reported cases included elements of inadequate or bad 
communication [41]. In addition, a number of international studies have shown failure in 
communication to be linked to increasing malpractice rates [42-44].  
In 2015, the Consumer Council of Norway interviewed 1000 patients, and found that one 
third  had at least one bad experience from their encounter with the Norwegian health care 
system in  the past 5 years, and 48% related this experience to inadequate communication 
[45]. As a result, an official web site was created (#syktvelkommen) where Norwegian 
patients are encouraged to share their experience.  
Research shows that well-designed physician training programs increase communication 
skills, as well as patients’ experience with communication [46, 47]. However, a Cochrane 
16 
review of communication skills training for health professionals in cancer care concluded that 
while various types of training appear to improve some types of communication skills, they 
fail to demonstrate any effect on patients’ mental or physical health [48].  
Communication training is provided to all Norwegian medical students  throughout their 
education [49]. This training is delivered through separate courses as well as being integrated 
throughout other parts of their studies. Ironically, there is a deterioration in communication 
skills as medical students enter clinical practice, a phenomenon believed to be caused by 
observing other physicians’ bad habits [50]. In 2017, mandatory competency modules that 
include communication skills have been introduced for all clinical specialties in Norway. In 
addition, the clinical communication model “Four habits” has been implemented in some 
Norwegian hospitals [51, 52].  
1.3 Elements of communication 
Communication in the medical setting is complex. Due to this complexity, we have chosen to 
look more deeply into selected elements of patient and physician verbal behavior that are 
particularly relevant to this thesis. 
1.3.1 Question asking 
Previous research has demonstrated a positive relationship between the number of questions 
asked by patients and the amount of information exchanged in the medical encounter [53]. 
Active patient behavior like asking questions contributes to a patient-centered approach [54]. 
In addition, research shows that patients who actively participates in the medical encounter 
receive more facilitating communication from their physicians [55].  
The frequency of questions asked by patients varies across cultures and settings [35, 56, 57]. 
In a study by Street et al. [55] , lung cancer patients asked more questions than patients in 
primary care or patients with systemic lupus erythromatosus. In an Australian study, newly 
admitted cancer patients asked on average 11 questions [57], while an Italian study found that 
breast cancer patients asked on average 18 questions during their first oncology consultation 
[35]. On the other side, seriously ill cancer patients in an Australian palliative care unit asked 
only three questions during consultations [56].  
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Studies have shown that the number of questions asked by cancer patients is related to patient 
characteristics such as level of anxiety [56], preferred level of control [58], age (older patients 
tend to ask fewer questions) [34]  and the patients’ educational level [34, 55]. Regardless, in 
the study by Street et al. [55], which revealed an association between question asking and 
patients’ educational level, the strongest predictor of question asking behavior was 
physicians’ partnership building and supportive talk. However, there is evidence that 
physicians’ endorsement of question asking alone may be insufficient to increase the number 
of questions [56].  
There is increased attention for triadic consultations, in which a caregiver accompanies the 
patient. In a study of oncology “bad news” consultations, 80 % of patients were accompanied 
by one or more caregivers [34]. The study found that the caregivers asked more questions 
than the patients themselves, illustrating the important role of caregivers in medical 
communication.  
1.3.2 Emotional cues and concerns 
One of the challenges physicians face in medical consultations is to be able to respond to 
patients’ emotional cues of concerns, which is often related to the patients’ medical condition. 
Cancer patients may experience emotional distress throughout the entire disease trajectory 
[59-62].  In a study of more than 3000 UK cancer patients, approximately one quarter met the 
criteria for clinically significant emotional distress [63]. In this study, patients’ emotional 
distress was associated with younger age (<65 years), female gender and having active 
disease. In a hospice setting, Heaven et al. [64] found a strong positive association between 
psychological distress and the number of emotional cues and concerns expressed by patients. 
A review article from 2007, addressing emotional cues and concerns, found the definitions of 
cues and concerns and the methodological approaches to differ widely [65]. The lack of 
consensus in coding emotional cues and concerns inspired a network of researchers to develop 
and validate a coding manual known as “The Verona coding definitions of emotional 
sequences (VR-CoDES)”, which is available online on http://www.each.nl.  
The developmental process is described in an article by Zimmermann et al. [66]. In this 
article, an emotional concern is defined as a clear expression of an unpleasant emotion, where 
the patient explicitly verbalizes this emotion. An example of an emotional concern might be: 
“I am worried about losing my hair”. An emotional cue is defined as a verbal or non-verbal 
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hint, which suggests an underlying unpleasant emotion, but lacks clarity. There are different 
sub categories, but examples could include crying, sighing, and unspecific words/sentences to 
describe emotions like: “Everything seems useless”. 
In a later work, a manual for coding physicians’ responses to emotional cues and concerns 
was developed [67]. A response to a cue or concern is described as either explicit or non-
explicit. An explicit provider response includes a precise reference to the expressed cue or 
concern, while a non-explicit response lacks a reference. This response can be subdivided into 
focusing on the content or the emotion. Additionally, the provider responses can be classified 
to produce or reduce space, and each emotional cue and concern can be coded based on how 
and by whom it was initiated. 
Physicians tend to be more responsive to patients’ information needs than to their emotions 
[68]. A Norwegian study from 2011, in which 96 videotaped consultations from a general 
teaching hospital were included, revealed that among 163 observed emotional cues and 
concerns, half of them were given reduced space responses, not allowing patients to further 
address their worries [69]. Another study showed that questions from patients and caregivers 
can include an emotional aspect, but is often responded to by providing space for the content, 
not the affective component [70]. In a study by Zacharie et al. [71], patient-perceived 
physician communication skills were related to the patients’ satisfaction, distress and self-
efficacy following the consultations.  
1.3.3 Shared decision making (SDM) 
Initially, evidence-based medicine focused on research evidence relevant to a clinical 
problem. Gradually, the definition of evidence-based medicine has expanded to include fields 
as clinical expertise and patient values [72]. This evolution is reflected in the national laws 
concerning patients’ rights, which legislates the patients right to participate in SDM [73].  
SDM in the medical setting has been defined as an encounter in which at least two 
participants – physician and patient – are involved; both parties share information; both 
parties take steps to build a consensus about the preferred treatment; and an agreement is 
reached on the treatment to implement [74]. One of the key assumptions in SDM is that the 
provided information is comprehensible and adapted to the individual patients’ need [75]. 
SDM is particularly desired for preference-sensitive treatment decisions, in which multiple 
options with less clear evidence exists. For patients at the end of their lives, there is a growing 
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accept that choosing quality of life over length of life can be a rational option [76]. On the 
other hand, there is reason to believe that SDM is not yet standard practice, even in these 
situations [77, 78].  
In resent years, the number of SDM publications in scientific journals have increased 
substantially [79]. In a systematic review from 2015, SDM (when perceived by patients as 
occurring) was related to improved affective-cognitive outcomes [80]. SDM has also been 
linked to better adherence to medication and improved clinical outcomes [81]. There is 
increasing support that SDM can reduce costs of care when patients are faced with 
preference-sensitive decisions [82]. Because of the lack of empirical data, there is no data to 
determine if SDM can affect malpractice litigations [83]. 
There is a clear relationship between cancer patients’ prediction of prognosis and their 
treatment-preferences, leading to patients overestimating their life expectancy to favor life-
extending therapy [32]. A well-known study by Temel et al. [84], has demonstrated that 
misunderstanding one’s prognosis can contribute to poor decision making and poor quality of 
life and possibly decreased survival. 
A meta-analysis by Singh et al. [85] showed that roughly 50% of patients diagnosed with 
cancer preferred to have a collaborative relationship with physicians in treatment decision 
making. The remaining patients were split equally between preferring active and passive 
roles. In the same study, most patients experienced the decision making role they preferred, 
but about 40% of patients experienced discordance between their preferred and actual roles. 
Gattellari et al. [86] found satisfaction to be highest for patients who indicated a collaborative 
role in decision making. The same study showed that role mismatch between preferred and 
perceived roles of SDM was associated with reduced emotional wellbeing, especially 
affecting anxiety levels. 
In a Norwegian study of 60 patients with newly diagnosed cancer, only 8.3 % wanted an 
active role, 29 % preferred a collaborative role, while 62.7 % wanted a passive role in 
treatment decision making [87]. These findings indicate that relatively few Norwegian 
patients want to have an active role in SDM, compared to results from international studies. 
Recent research has shown that patients asking targeted questions can influence physicians 
towards exhibiting more SDM behavior [88]. Contrary, other evidence indicates that changing 
patients’ behavior might not be sufficient to facilitate SDM [89]. In a study of 252 men with 
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localized prostate cancer, the researchers found that physicians informed patients of options, 
risks and benefits, but infrequently engaged them in the core SDM process (discussing 
options, risks and benefits , and preferences) [90]. Interventions targeting patients and 
healthcare professionals together show more promise than targeting only one part alone [91].  
1.4 Improving patients’ communication 
A systematic review of intervention studies designed to increase patient participation in 
medical consultations found that half of the interventions did so [92]. Communication aids 
aim to provide patients with tools to improve elements of communication. Note taking, 
consultation audio record (CAR) and consultation summaries are examples of communication 
aids designed to facilitate the patients’ recall of information [93, 94]. Moreover, 
encouragement to develop an own list of questions or a question prompt list (QPL) can help 
patients receive personalized information during medical encounters [94].  
Patient decision aids are designed to support patients in making decisions regarding their own 
health that are congruent to their values in life [95]. Decision aids are developed for different 
cancer diagnosis and settings [96, 97] and has been developed as book/booklets [98] or videos 
(www.minebehandlingsvalg.no). Furthermore, decision aids can be computerized/online to 
provide patients with interactive and individualized content [99]. A recent Cochrane review 
concluded that patients who were exposed to decision aids were better informed and probably 
had a more active role in decision making [100]. 
Communication aids and decision aids can be part of a preparation package, involving 
multiple interventions [89]. Evidence also exists, that patient coaching can improve patient-
physician communication during medical encounters [101]. 
In this project, we have focused on two communication aids: QPL and CAR. 
1.4.1 Question prompt list (QPL) 
A QPL is a structured list of questions patients could want to ask their physician. QPLs are 
designed to increase patient participation during the consultations by enabling patients to 
articulate questions that are important to them, and thereby obtain more customized 
information. QPLs are patient mediated interventions, with patients leading their use in the 
consultation. They have been developed for patients in different health care settings [102, 
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103], including various areas of cancer care [104-106]. Implementing QPLs in routine care is 
feasible, but identifying and addressing practical implications before implementation is 
proposed to be essential [107, 108]. 
In a review by Dimoska et al. [109] from 2008, the authors concluded that QPLs can increase 
the number of questions asked during consultations, especially concerning prognosis. 
Evidence also indicates that QPL interventions may influence both psychological (e.g. 
anxiety) and cognitive outcomes (e.g. recall of information) [110]. A shortened consultation 
length, reduced anxiety and better information recall has been found when the physicians 
explicitly addresses the QPL during the consultation [57]. Provision of a QPL along with 
physicians’ endorsement of its’ use, assisted terminally ill Australian cancer patients to ask 
more questions and promoted discussions about prognosis and end of life issues [111]. 
Equally important, providing the QPL to this vulnerable group of patients did not increase 
patient anxiety or impair satisfaction. In another study in an advanced cancer setting, 
combining a QPL with coaching and physician communication training, improved patient 
centered communication but did not affect secondary outcomes [112].  
In an implementation study from 2012, 44% of patients provided with a QPL reported to have 
used it during the consultation [107]. In comparison, results from a survey among patients 
who were prompted to use communication aids, showed that 81 % of respondents had 
generated their own list of questions when prompted to [94]. Considering this result, the 
authors suggested QPLs to start with a blank space for patients to list their own unique 
questions.  
Usually, QPLs are developed from information provided by patients and health care workers 
through focus groups and interviews [109]. Most QPL research has been done in areas where 
English is the main language. It is not clear to what extent this type of intervention translates 
to different cultural settings. In a study of a QPL for patients with advanced cancer in the final 
year of life [105], feedback from patients and healthcare professionals resulted in two separate 
US and Australian versions. The two versions diverged in terms of language, and two 
questions regarding treatment and costs were excluded from the Australian QPL as they were 
irrelevant to patients. Because of their experience, the authors of this study argued for QPLs 
to be tailored to individual populations [105]. 
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No standard method exists for translating and adjusting QPL to different cultures and settings.  
In the cultural adaption of an Australian QPL to Italian [113], a cross cultural adaption 
process described by Guillemin [114] and Beaton [115] was used. In this Italian study, the 
expert group replaced the Italian word for “cancer” with “tumor” or “my illness”, suggesting 
Italian patients to be less willing to accepting a more direct language. 
No cancer specific QPL has previously been developed, translated or adapted to a Norwegian 
health care setting. 
1.4.2 Consultation audio recording (CAR) 
A CAR is an audio recording of a consultation, and can serve as a communication aid when it 
is provided to the patient. In 2002, Tattersall et al. [116] strongly recommended CAR as a 
research tool, and also as a patient communication aid. In an RCT by Hack et al [117], men 
with prostate cancer were given a CAR of their initial consultation, and the patients who 
received the CAR reported to be significantly more informed about treatment alternatives and 
treatment side effects. Similar results were reported in a RCT of patients with esophageal 
cancer [118], where patients who received a CAR demonstrated significantly better 
information retention, without experiencing adverse psychological outcomes. 
A Cochrane review from 2008 including 16 studies, concluded that providing adult cancer 
patients with CARs was beneficial, as patients in the reviewed studies used the CAR to 
inform family and friends, and reported better recall of information [119]. Moreover, some of 
these studies reported increased satisfaction with consultation, but no effect was found on 
psycological outcomes or quality of life. 
In a recent study of more than 4000 patients, providing CAR or the combination of QPL and 
CAR improved patients’ perception of being adequately informed [120]. In this non-cancer 
setting, 31% of the CARs were replayed within 90 days. Among cancer patients, the reported 
replay of CARs seems to be higher. A review from 2014 reported a replay rate between 54 
and 100 % [121]. The combination of QPL and CAR has been sparsely explored in oncology, 
except for a small study among men newly diagnosed with prostate cancer [122]. In this 
study, the 30 men assigned to receive the interventions, reported more active roles in medical 
decisions and had lower levels of anxiety 6 weeks after the consultation. 
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Even though identified as a helpful tool, there seems to be barriers to request a CAR. In a 
study published in 2012, less than 20 % of breast cancer patients reported to have successfully 
recorded the consultation when prompted to by a “Decision service team” [94]. Barriers to 
provide patients with a CAR also exists among hospital administrators and physicians, and 
their concerns were mainly that CARs could negatively affect the communication process and 
that patients could misunderstand information [108, 123]. In addition, they had worries about 
the legal aspect. As more people are in possession of a smartphone, there are reasons to 
believe that more patients will request to make a CAR. As proposed by Elwyn [91] in 2014: 
“It is doubtful to think that medicine could remain immune to our growing capacity of easily 





2 AIM OF THE THESIS  
 
The main goal of this study was to investigate the provision of a QPL and a CAR in a 
Norwegian oncology outpatient clinic, and to evaluate these communication aids’ effect on 
clinical communication and patient outcomes. 
More specifically, the aims of the thesis are: 
 to develop a culturally adjusted Norwegian QPL. 
 
 to study natural occurring questions and emotional cues and concerns, and 
their relationship to patient characteristics and physician SDM behavior. 
 
 to investigate the QPLs effect on patient question asking and physician SDM 
behavior. 
 






3 SUBJECTS AND METHODS  
3.1 Development of the Norwegian QPL (Paper I) 
The aim of this study was to develop a culturally adapted Norwegian QPL. A combined 
method approach, including literature review, focus groups and a survey, was used to adjust 
an existing Australian QPL into a cultural sensitive Norwegian version. As a starting point we 
adopted the Australian QPL “So you have cancer…”, which was developed by researchers at 
the University of Sydney [109]. This QPL contains 49 questions divided into 12 domains (see 
Appendix 1) and applies to most areas of cancer care.  
3.1.1 Method and study population  
The QPL was first translated into Norwegian according to EORTC quality of life translation 
process [124]. An extra question was added: “Is it normal to experience pain having my type 
of cancer, and if I experience pain, where can I get help for pain relief.” This question was 
added to address the finding in a nationwide survey of over 7000 Norwegian cancer patients, 
indicating that Norwegian cancer patients lacked information about pain/pain relief [125]. In 
addition, a contemporary Norwegian study reported that approximately 35 % of cancer 
outpatients experience pain [126]. 
Focus groups were conducted to ensure content validity [127]. Transcripts from the focus 
groups were subjected to a thematic analytic approach [128]. After slightly rephrasing of 
some of the excising questions and the development of three new questions, the revised QPL 
was reviewed by patients in a survey. The recruitment processes, collecting of data and data 
management are thoroughly described in Paper I of the thesis [129]. 
Eighteen patients participated in one of the three focus groups and they were recruited from a 
support center for cancer patients and survivors. Twelve of them (67 %) were women, and 
mean age was 54 years. Participants in the survey were recruited from the Cancer Outpatient 
Clinic at UNN and eligibility criteria included a minimum of 3 months experience as a cancer 
patient and being aged 18 to 75. Respondents to the survey were 16 (52 %) women and 15 (48 
%) men. Mean age was 55 years.  
Disease characteristics were not obtained for participants in this part of the study (focus 
groups and survey), and there are concerns that different cancer diagnoses and especially 
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different stages of the disease could have affected the result. For instance, there are reasons to 
believe that an issue such as rehabilitation (as emerged in our focus groups), might be more 
relevant to patients that have completed cancer treatment than to those with newly diagnosed 
or advanced cancer. 
The limited information about cancer site/stage of the disease is a weakness and can have 
affected the sample representativeness in this part of the study. 
Statistical analysis 
This work was mainly qualitative in nature. We conducted descriptive statistics to create a 
summary of responses and to display a percentage distribution of responses to each question 
in the survey. Data were handled using SPSS version 22/23. 
3.2 Assessing patient-physician communication (Paper II and III) 
In this part of the project, we wanted to explore central elements of patient-physician 
communication in ordinary consultations and the effect of introducing the communication 
aids QPL and CAR. 
3.2.1 Study population 
All physicians at the Cancer clinic UNN were asked to participate in this study, except for 
four senior physicians that were involved in this project (senior physicians being specialists in 
oncology). Everyone accepted the invitation, except for one physician who did not participate 
in the last part of the project (providing QPL and CAR). Written informed consents were 
collected prior to the study, and each of the 22 participating physicians had between one and 
nine study consultations. Male (56%), senior (61%) physicians, conducted most of the 
consultations.  
Patients were recruited from the Cancer outpatient clinic UNN, which receives patients with a 
wide range of diagnoses from the three northernmost counties in Norway. Anita Amundsen 
(AA) identified the patients from the participating physicians’ outpatient lists. Eligibility 
criteria included age 18-75, Norwegian speaking and being able to fill inn questionnaire data. 
The patients in the combined group also had to have access to a computer to play the audio 
file. 
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Eligible patients were sent a letter of invitation, and if the patient accepted the invitation, 
he/she met with the study nurse to sign an informed consent before completing the first 
questionnaire. The following consultation was audio recorded by a handheld device put 
between the physician and the patient. 
This part of the study included 93 patients, 50 % male and mean age of 60 years. 
The study was designed as an exploratory study with a quasi-experimental design (see Figure 
1). Data collection for the control group was completed prior to the intervention groups to 
avoid any learning effect on physicians.  Patients were recruited in three different time spans, 
assuming no seasonal variation. The control group received no interventions and was 
recruited between May and June 2014. The second group (receiving the QPL in advance of 
the consultation) was recruited between May and June 2015. The last group (receiving the 
QPL before and a CAR after the consultation), was recruited between November and January 
2015/16. These groups are hereafter called the Control group, the QPL group and the 
Combined group, respectively. 
 
Figure 1 – Flow diagram of the study design. 
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3.2.2 Analysis of the consultation audio recordings 
Secretaries at the Cancer Department transcribed the audio files of the consultations verbatim. 
The following elements were coded from the transcripts: Number and type of questions from 
patients and any caregivers (separately) and physicians’ verbal SDM behavior. In the Control 
group, emotional cues and concerns were additionally coded, along with physicians’ response 
to them.  Two psychology students at the Master level were trained to do the coding of the 
study consultations. 
Questions from patients and caregivers 
A Norwegian coding manual was developed to ensure coding agreement. The manual was 
developed after considering the question categories in the Norwegian QPL and four English 
coding manuals from previous QPL studies [57, 111, 130]. The manuals were provided by 
prof. Phyllis Butow, who has done extensive work on developing and testing QPLs along with 
her Sydney research group. After considering all manuals, a Norwegian manual was 
developed to include the most appropriate elements of both physician and patient/caregiver 
verbal behavior for this study. 
If physicians invited patients to ask questions was coded as either absent, basic or extended, 
and whether it happened in the first/middle/last part of the consultation. Basic endorsement 
was coded when the physician only asked if the patient had any questions. Extended 
endorsement was coded when the physician in any way emphasized the importance of asking 
questions. In consultations where the patient received the QPL, the coding included if the 
physician addressed the QPL and in what part of the consultation it occurred (beginning, 
middle or end of the consultation). If the patient preceded the physician in addressing the 
QPL, it was coded as patient-initiated. If neither the physician nor the patient addressed the 
QPL, this behavior was coded as absent.  
Patients’ and caregivers’ questions were coded into one of 14 categories, and later merged 
into seven related topics (Table 1). 
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One of the coders performed coding of questions in each consultation, except for 27 
consultations where the coding was done by both coders. Inter rater reliability for total 
amount of questions was computed using intra class correlation coefficient (ICC=0.84) and 
indicated a good inter rater reliability.  
Table 1 – Coding categories and merged topics. 
Coding Categories  Topics 
1. Treatment Treatment 
2. Practical Practical 
3. Prognosis Prognosis 
4. Diagnosis 
The disease 5. Tests 
6. Sources of information 
7. Treatment options 
Quality of 
treatment 
8. Multi disciplinary team 
9. Optimal care 
10. Life style 
Support 11. Costs 
12. Relatives 
13. When and how to ask questions 
Other 
14. Other 
Emotional cues and concerns 
Patients’ emotional cues and concerns, and physicians’ responses were coded from the 
transcripts according to the Verona coding definition of emotional sequences (VR-CoDES) 
and provider response (VR-CoDES-P) [66, 67]. Kristine Lingen (KL) coded the transcripts 
after completing training with training material provided at the EACH website 
(www.each.eu). The training was supervised by Svein Bergvik (SB), a member of the group 
of developers of the VR-CoDES. Coding of each exercise was successively discussed with the 
supervisor until the coding was in accordance with the recommended values in the training 
material. During the coding process, the coder and supervisor met regularly to review the 
coding and discuss cases of uncertainty. 
Due to the limited sample of consultations (the Control group only) and the relative low 
frequency of emotional cues and concerns, the subtypes of cues were not coded (only the 
frequency of events). 
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Physician SDM behavior (OPTION) 
The OPTION scale measures to what extent physicians involve patients in SDM in a medical 
encounter [131]. The scale includes 12 items evaluating different physician SDM behavior. 
All items are rated from 0 to 4, where 0 indicates absence of SDM behavior and 4 indicates an 
excellent performance by the physician. 
The OPTION scale was translated according to best practice. Translators fluent in English 
with Norwegian as the main language made two separate translations, which were merged 
into one Norwegian translation by SB and AA. A professional translator fluent in Norwegian 
with English as the main language back translated this version into English. All translations 
were discussed by SB and AA to decide on a final Norwegian version. 
SB and AA trained the two coders in our study. After three sessions of group training on 
transcripts of consultation sequences from the control group, individual coding was 
performed. All elements of each consultation were then discussed to agree on the correct 
coder response. For 11 consultations, the coding was decided upon consensus agreement 
between the two coders, SB and AA. Following this initial training, the rest of the transcripts 
were coded separately. Coding agreement was checked regularly (after each 10 to 15 
consultations) to keep consistent coding throughout the process. 
The data was analyzed based on the mean of the two rater scores (except for the 11 consensus 
scored consultations), and the sum OPTION score was transformed into a scale ranging from 
0 to 100 as recommended by the developers of the scale [131].  
Inter rater reliability was computed (from 82 consultations) using intra class correlation 
coefficient (ICC=0.85) and indicated good inter rater reliability. 
3.2.3 Questionnaire data 
Patients were provided with questionnaires just before and one week after the study 
consultations.  
Patient characteristics 
Data on patient characteristics were gathered in the pre-consultation questionnaire and 
included age, gender, marital status, education, occupation and main language.  
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Anxiety and depression 
The patients’ anxiety level was measured before and one week after the consultation, using a 
Norwegian version of the Hospital Anxiety and Depression Scale (HADS) [132]. This widely 
used 14-item scale is a self-assessment tool that measures current level of anxiety and 
depression, and responses indicates the patients’ assessment of the past week. The two seven-
item subscales have the minimum value of 0 and maximum value of 21. A score of 0–7 on 
any of the subscales are regarded to be in the normal range, score of 8–10 being suggestive of 
mood disorder and a score of 11 or above indicating probable cases of mood disorder [133]. 
Quality of life 
Health related quality of life was measured before and one week after the consultations using 
the European Organization for Research and Treatment of Cancer (EORTC) QoL-C30 
Version 3.0 [134]. This is a 30-item quality of life instrument for use in clinical trials, and it is 
found to be a reliable and valid measure of quality of life of cancer patients [135]. It consists 
of multi item scales as well as single items: five functional scales (physical, role, cognitive, 
emotional and social), three symptom scales (fatigue, pain, nausea/vomiting), single items 
assessing dyspnea, insomnia, appetite loss, constipation, diarrhea and financial impact, and a 
global health and quality of life scale. 
Patient satisfaction 
Patient satisfaction can be defined as “a health care recipients’ reaction to salient aspects of 
the context, process and result of their service experience” [136]. Patient satisfaction 
measurements are often used as quality assessment and to identify areas of improvement in 
health care. 
The Cancer Patient Experiences Questionnaire (CPEQ) is a Norwegian validated self-report 
instrument covering important aspects of outpatient cancer care and it originally consists of 6 
subscales: nurse contact, physician contact, information, organization, patient safety and next 
of kin [137]. 
The study patients’ experience with the consultations was obtained one week after the study 
consultation. In this project, we only used the scales concerning physician contact (7 items) 
and information (7 items).  
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The scale concerning physician contact includes questions about the patients’ experience of 
the physician; physician being updated on treatment, followed up on side effects, took 
concerns seriously, cared for the patient, provided enough time for dialogue, was 
understandable and was competent.  
The scale concerning information included the information the patient received concerning; 
the illness, treatment options, examination/test results, side effects of treatment, effects of 
treatment, pain to be expected and pain relief.  
The possible scores on both scales ranges from zero to 100, a higher score indicating higher 
satisfaction. 
Control preference scale 
The Control Preference Scale (CPS) [138] was used to address the patients’ preferred level of 
involvement in treatment decision making in the questionnaire before the study consultation. 
The control preference construct is defined as “the degree of control an individual wants to 
assume when decisions are being made about medical treatment”. The CPS has been proven a 
valid and reliable measure of preferred roles in health care decision making [139]. The CPS 
originally consisted of 5 cards, but has also been used in questionnaires [140]. The CPS 
differentiates between patients preferring an active, passive or collaborative role in decision 
making. It has also been used to identify to what extent patients experienced to be involved in 
treatment decisions [141, 142]. In our project, we used a  Norwegian CPS version from a 
previous project and made minimal changes to the wording [87]. 
Patients’ experience with the QPL 
The patients were asked to evaluate the QPL one week after the consultation by responding to 
the following four questions:  
1. Did you read the booklet “Spørsmål til kreftlegen” before the consultation?  
2. Did you use the booklet “ Spørsmål til kreftlegen” during the consultation?  
3. Would you find the booklet “Spørsmål til kreftlegen” useful further, in the context of your 
cancer? 
All three previous questions could be answered by ticking either yes, no or do not know.  
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4. Do you think the booklet “Spørsmål til kreftlegen” served as a useful tool for you? 
This question could be answered by ticking: “not at all”, “to a minor extent”, “to some 
extent”, “to a large extent” or “to a very large extent”. 
Physicians’ experiences with the QPL 
The physicians were addressed in a questionnaire after the final patient was included. The 
questionnaire consisted of four questions and one area reserved for other comments. The four 
questions were: 
1. Did any of your patients use the booklet “Spørsmål til kreftlegen” during an outpatient 
consultation? 
The question could be answered by ticking either yes, no or do not know.  
2. Do you think the booklet “Spørsmål til kreftlegen” served as a useful aid for the/those of 
your patients who used it? 
3. Was the booklet “Spørsmål til kreftlegen” a useful aid for you in conversation with your 
patient(s)? 
These two question could be answered by ticking: “not at all”, “to a minor extent”, “to some 
extent”, “to a large extent” or “to a very large extent”. 
 
4. Did you feel that the consultation length was changed in these consultations? 
The question could be answered by ticking: “yes, more time consuming”, “yes, less time 
consuming”, “no” or “do not know”. 
Patients’ experience with the CAR 
All 32 patients receiving a CAR had five extra questions exploring their use of the CAR in the 
post consultation questionnaire:  
1. Were you offered a CAR after the consultation? 
The question could be answered by ticking either yes, no or do not know.  
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2. How many times did you listen to the CAR? 
 The question could be answered by ticking none, 1-2 or 3 and more. 
3. Did you find the CAR to be a useful to you? 
 This question could be answered by ticking: not at all, to a minor extent, to some 
extent, to a large extent and to a very large extent. 
4. Did anyone, except for you, listen to the CAR? 
This question could be answered by ticking: spouse/partner, children, other family/friends, 
health personnel or no other. 
5. If neither you nor anyone else listened to the CAR, can you specify a reason? 
 An answer could be given in free text. 
 
3.2.4 Statistical analysis 
A sample size calculation was performed to be able to detect a significant differences in 
number of questions between patients receiving the QPL and the Control group. Initially there 
was no previous research from a Norwegian setting, and sample size calculation was based on 
international findings. We expected Norwegian patients to ask on average 12 questions 
(SD=6) during consultation. We assumed a 30% increase to be clinical significant. We chose 
a 2:1 ratio (merging the QPL and combined QPL and CAR vs no intervention). The sample 
size calculation revealed that we needed 27 patients in the control group to have 80% power 
to detect a difference on a 5% significance level.  
Descriptive statistics were used to display frequency. Inter rater reliability for coding of the 
OPTION score and questions from patients and caregivers were computed by the Intra class 
correlation coefficient (ICC). 
In the Control group (Paper II) simple and multiple linear regression analyses were used to 
find associations between patients’ and caregivers’ question asking behavior, emotional cues 
and concerns (dependent variables) and patient/consultation characteristics. Further, the 
Pearson correlation coefficient was used to address the relationship between question asking 
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and emotional cues and concerns. To explore the relationship between question asking and the 
OPTION score, we recoded consultations into three groups according to the number of 
questions asked: Few (0–10), medium (10–20) and many (> 20) questions. Oneway ANOVA 
was used to compare OPTION scores in these groups and independent sample T-test was used 
to compare OPTION scores in consultations where emotional cues or concerns appeared, to 
consultations where they did not appear. When including anxiety as a covariate in these 
analysis, ANCOVA was used.  
Differences between the control group and the two merged intervention groups (Paper III) on 
total amount of questions, consultation length and the OPTION score were analyzed by 
independent sample t-test. Differences regarding subgroups of questions were analyzed with 
Mann-Whitney U-test, due to a skewed distribution with high proportion of zero counts. In 
the questionnaire data, differences between the three individual groups were analyzed using 
ANOVA and ANCOVA model. Effect sizes were provided by calculating Cohen´s d and 
Partial Eta Squared. 
All statistics were performed using Statistical Package for the Social Sciences (SPSS) version 
23. 
3.3 Ethics 
This study was performed according to the Code of Ethics of the world Medical Association 
(Declaration of Helsinki). Before starting this study, an application was directed to the 
Regional committee for medical and health ethics (REK nord). It was from their part declared 
as a quality assurance project and the study was then formally approved by the Data 
Protection Officer at UNN. 
Cancer patients often experience high stress, and introducing a clinical trial in this patient 
population should therefore be considered carefully. There has been concerns that 
communication aids can lead to negative health effects for patients, like more anxiety. 
Multiple studies exploring QPLs and CARS during approximately 20 years have not given 
evidence to support this [121, 143].  
All patients and physicians gave a written informed consent after being informed and before 





4 MAIN RESULTS  
Paper I 
In this paper, we aimed to culturally adjust an Australian QPL to be suitable in a Norwegian 
oncology setting. We used a combined method approach, including literature review, focus 
groups and a survey. 
This study showed that most questions from the original QPL were considered both useful 
and understandable for Norwegian cancer patients. As expected, some questions concerning 
prognosis were found unpleasant by the patients, but the same questions scored high on being 
useful. Focus groups identified three questions to be added: Accompanying relatives, children 
as next of kin and rehabilitation. Questions regarding clinical studies, multi-disciplinary teams 
(MDT) and public versus private hospitals were rated lower on usefulness. After discussions 
in the research group, the question concerning private versus public hospitals was excluded. 
Likewise, two questions regarding clinical studies and MDT were excluded and two 
additional questions regarding the same topics were rephrased in the Norwegian QPL.  
The results from this study suggests that adoption of QPLs require some adjustments to the 
local cultural context and a combined method approach might be a useful model. The final 
Norwegian QPL contains 50 questions and is culturally adjusted to a Norwegian setting. 
Paper II 
In this observational study, we explored central elements of clinical patient-physician 
communication in primary consultations in a cancer outpatient clinic.  
On average patients asked 17 questions (SD 15) and expressed 1.9 emotional cues or concerns 
(SD 1.9) in these 31 audio-taped consultations. Both question asking and expression of cues 
and concerns increased with level of anxiety. Most questions from patients and caregivers 
pertained to treatment and practical issues, while questions concerning prognosis and 
treatment options were few. The mean OPTION score was 12 (SD 7.9) and was neither 
associated with questions from patients/caregivers nor the presence of emotional cues and 
concerns from patients. This study demonstrates that despite patients being active by asking 
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questions, observed physician SDM behavior measured by OPTION was low and not 
associated with patient verbal behavior during consultation. 
Paper III 
In this exploratory study, we compared two groups of patients receiving either a QPL or 
combined QPL/CAR, to a control group.  
The study found that patients receiving the QPL asked more questions concerning prognosis 
(p<.0001), the disease (p=.006) and quality of treatment (p<0.001) than patients in the control 
group, without detecting a significant difference in total number of questions. Providing 
patients with the QPL had no impact on the OPTION score. An increase in mean consultation 
length was observed when patients received the QPL compared to the control group (44 vs. 36 
minutes; p=.028). Patients rated both the QPL and CAR positively, but no difference was 
detected on anxiety/depression/QoL between any of the groups. The study concludes that 
provision of a QPL facilitates patients to ask a broader range of questions, but increases the 
consultation length.  
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5 GENERAL DISCUSSION  
5.1 Discussion of main results 
5.1.1 Norwegian cancer patients’ information need 
In the process of adapting an Australian QPL to a Norwegian setting, we found that the 
information need of Norwegian cancer patients was comparable to that of Australian cancer 
patients. However, we did find some differences. After consulting Norwegian cancer patients 
through focus groups and a survey, three new questions were added to the Norwegian QPL, 
while three questions from the original Australian QPL were removed. In addition, the 
consensus group (consisting of two oncologists and one oncology nurse) agreed on some 
minor changes to the wording of questions after reviewing feedback from participants in the 
focus groups and the survey.  
Prior research have revealed cultural and organizational disparities when translating quality of 
life questionnaires to various populations [114, 115]. In the process of developing a QPL for 
patients with advanced cancer, US health professionals were more reluctant about talking to 
patients about prognosis than their Australian colleagues [105]. Additionally, in a project 
adapting a QPL to Italian, researchers exchanged the word “cancer” with “tumor/my illness”  
[113]. In the Italian study, an expert group (consisting of translators, one oncologist, one 
methodologist, one psychologist, one sociologist and one linguist), decided to not use the 
word “cancer” in the QPL because its’ strong “connotation of malignancy”.  
Our research did not reveal a need to moderate the language to protect patients from feeling 
distressed. As shown in previous studies, central European countries traditionally have 
maintained a preference to conceal medical information from the patients in a time when US 
physicians started favoring disclosure [144-147]. The development of the Italian QPL was 
part of a project called HUCARE (Humanization of cancer care), and included actions to 
improve patient-physician communication. Despite replacing the word “cancer” in the Italian 
QPL, the researchers acknowledged that some Italian experts thought the time was ready for 
the word to be used with patients. It is worth noting that cancer patients were not consulted, so 
their opinion is unknown.  
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No concerns were raised about the need to moderate the language for our study, and 
discussions of wording in the consensus group pertained to improve the questions to be in line 
with everyday-spoken Norwegian. The feedback from the survey also did not indicate any 
need to moderate the language, suggesting that Norwegian cancer patients are more similar to 
their Australian counterparts in accepting a more direct language. 
There are reasons to believe that there is a need to adjust QPLs to different health care 
systems based on how they are organized [105]. The subject ‘children as next of kin’ was 
found by the two first focus groups in our study to be missing from the original QPL. This 
was a contemporary theme, reinforced in the Norwegian Health Professions Act in 2009 
[148]. The Australian QPL “So you have cancer…” does not include any questions related to 
children as next of kin. On the other hand, it includes a question concerning private versus 
public health services, which was evaluated to be less useful by our survey respondents and 
removed from the Norwegian version as the Norwegian health service is mostly public.  
The QPL “So you have cancer..” was advocated for in 2008 by a Sydney research group. The 
subject children as next of kin’ was introduced  in a later Australian QPL (for advanced 
cancer patients), which was also developed at the University of Sydney [105]. The difference 
in the two QPLs is most likely due to the development in Australian health service. Such 
changes are also evident in the Norwegian health service where the number of citizens with 
private health insurance is increasing, and has exceeded half a million in 2017 [149]. The 
relevance of the question in the Australian QPL relating to private versus public health 
services could be greater to the Norwegian cancer patient in 2018 than it was in 2014 when 
the QPL for our study was developed. 
In the observational part of the study (Control group), we explored cancer patients’ 
information needs from transcripts of their first consultations at the outpatient clinic. Of the 
31 consultations reviewed, the majority of questions from patients and caregivers referred to 
treatment and practical issues. Even though our group of patients was actively asking 
questions, they asked very few questions regarding prognosis and treatment options. 
Prognostic questions from patients (and/or caregivers) occurred in only four of the 31 




A weakness in our study is the lack of data on what information physicians provided to the 
patients, which was not obtained/coded due to limited resources. For instance, patients’ few 
questions concerning prognosis could be due to information already provided by the 
physicians, or that patients’ clearly expressed reluctance to receive this type of information. 
Prior research shows that most cancer patients want prognostic information, yet this 
information is seldom provided, even when faced with terminal illness [19, 24, 25]. 
From the analysis of the 31 patient-physician consultations in the control group, we found that 
number of questions asked varied considerably between the different consultations. Further, 
the multivariable analysis revealed that the number of questions asked to be related to 
patients’ anxiety score prior to the consultation. Patients with high levels of anxiety in our 
study asked more questions. The relationship between the number of questions from patients 
and anxiety score has been identified in earlier studies [56]. However, what patient 
characteristics that are related to question asking varies between studies, and we did not find 
that the number of questions asked was related to age, education or level of control, as shown 
in previous studies [34, 55, 58]. 
5.1.2 Communication aids: QPL and CAR 
The patients in our study who were provided with a QPL asked a broader range of questions, 
including more questions concerning prognosis, the disease and quality of treatment. This is 
in line with previous studies, which found that QPLs help patients change their question 
asking behavior [57, 111, 130]. Similar to the results in our study, a review by Dimoska et al. 
[109] concludes that patients provided with a QPL tended to shift their focus away from 
disease history and treatment, to prognosis and diagnosis. There is evidence that physicians 
provide fewer details and less complex information to a passive patient [150]. There can be 
various reasons for patients to ask few questions, but a QPL can help patients to explore their 
own information need and to articulate questions. Our study did not include any analysis of 
what information the physicians gave. A study investigating the amount of information 
provided by physicians indicated a significant increase of information when patients are 
provided with the QPL [143].  
In our study, we recommended the physicians to address the QPL and to encourage the patient 
to ask questions as early in the consultation as possible. The first time when the physician 
signed the consent form, then by providing a written suggestion of how to encourage question 
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asking before each study patient and third a written suggestion along with the hand held 
recorder. Nevertheless, only 37 % of the physicians addressed the QPL in the first part of the 
consultations and 15% encouraged question asking. In the consultations where physicians 
addressed the QPL early, patients and caregivers asked on average 35 questions, compared to 
19 when the QPL was addressed later, suggesting an additional effect when physicians 
address the QPL early in the consultation. Despite a clear difference in number of questions, 
the consultation length was 45 minutes in both situations (unpublished results). 
For our study, all physicians in the Oncology department participated. In a study by Brown et 
al. [57], only nine physicians from two university hospitals were included. It is possible that 
in a study that only includes a few physicians the selection of physicians can favor those who 
are most interested in communication, which might affect the result. While QPLs are simple 
and inexpensive tools that can empower patients to ask relevant questions, physician training 
and motivation may be more challenging due to time constraints. One might expect patients to 
have unmet information needs in circumstances where they are given a communication aid 
like a QPL, but no time to ask questions. If the patient is only allowed to ask questions at the 
end of the consultation, there is no surprise that the consultation length increases. Due to the 
growing number of communication and decision aids that are developed, the use of these 
should be addressed in future courses in clinical communication to ensure that physicians are 
aware of how to encourage their use. 
Targeting physicians to address the provided QPL, was shown by Brown et al. [57] to shorten 
the consultation length. The investigators trained a random selection of physicians to address 
the QPL and to encourage question asking following a written protocol. In addition to the 
initial training, the physicians received personal feedback after five study consultations. The 
mean consultation length was 32 minutes when patients in the study received no intervention, 
compared to 29 minutes where a QPL was provided together with physician training. In the 
study by Brown et al. [57] it is worth noticing, that in the group of patients receiving the QPL 
without physician training, the consultation length increased to 34 minutes.   
Providing the QPL to patients increased the consultation length significantly in our study. The 
consultations in the control group lasted on average 36 minutes, compared to 44 minutes 
when provided with the QPL. A review of QPLs with the number of questions ranging from 
11 to 112, suggested that longer QPLs can increase consultation length [109]. In a review by 
Sansoni et al. [143] it was noted that the studies that found an increased consultation length 
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when using a QPL, were the studies with the positive findings (e.g. increased total number of 
questions, questions concerning prognosis). The effect of QPLs on consecutive consultations 
is sparsely investigated, and future research should address if the provision of extensive 
information in one consultation could reduce later information need and thereby possibly 
shorten future consultations. 
It is well known that time constraint is a frequently reported barrier to clinical change [108, 
151]. An increased consultation length when a QPL is provided might be a challenge due to 
focus on efficiency in the health sector. However, providing patients with all necessary 
information takes time. The provision of complex information concerning risks and benefits 
of the proposed treatment options should be done in a close dialogue with patients, to ensure 
the information is personalized and understandable. The QPL contributes to a patient-centered 
approach by empowering patients to ask a broader range of questions. The increased 
consultation length should be subject to further investigation, which could include identifying 
the optimal QPL length, physician training and the QPL effect on consecutive consultations. 
The second communication aid to be investigated in our study was a CAR. In a study of 168 
UK survey respondents, 69% indicated a desire to record clinical encounters [108, 152]. At 
the time of evaluation, one week after the consultation, only half of the patients in our study 
had listened to the CAR. This unfortunately limits our ability to conclude on the combined 
effect of a QPL and CAR on patient outcomes. However, it was well received by most patient 
who had listened to it, in accordance with previous studies [121].  
Neither the QPL nor the combination of QPL and CAR showed an effect on anxiety, 
depression or QoL in our study. We also did not find any significant difference in patients’ 
evaluation of physician contact or information retrieved, however, found a trend towards that 
those patients provided with communication aids evaluated their experience more positively. 
Most communication studies uses patient outcomes like anxiety, depression or quality of life 
as outcome measures. These measures can be influenced by numerous other factors, such as 
the disease itself and treatment. In the control group, anxiety level decreased significantly one 
week after the consultation, compared to pre consultation (unpublished results). At the same 
time, QoL decreased significantly from initial value, accompanied by a reduced role 
functioning, and increased fatigue and constipation scores, probably due to side effects of 
cancer treatment. While there are no consistent findings of reduced anxiety with the use of a 
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QPL or CAR, it is unlikely that these interventions would cause any unintended adverse effect 
on patients anxiety scores [119, 143]. 
Patient satisfaction ratings are important indicators of the quality of health care services, and 
can include patient satisfaction with their overall health care or patients satisfaction with their 
physician [153]. High patient satisfaction levels have been reported in several communication 
studies [154]. The high percentage of patients reporting high satisfaction in studies is called 
the ceiling effect, and makes it difficult to discriminate between responses and to monitor 
effect of interventions. In an essay, Steet [155] argues that communication measurements are 
complicated because communication behavior often has an indirect effect on different 
outcomes. He further argues that researchers should do more to model pathways linking 
communication to the process of interest. De Haes el al [156] argues that only by articulating 
the hypothesized relationship between specific communication elements and concrete 
endpoints, we have the chance to bring medical communication into the area of evidence-
based medicine. 
5.1.3 Shared decision making 
The Norwegian 1999 Patients’ Rights Act has been amended to ensure patients has the right 
to be involved in decisions concerning their own health [73]. While SDM is a process, it relies 
on patients’ receiving timely and personalized information about the disease and treatment(s) 
available. While the definition of SDM varies, it is accepted that it involves a decision of 
treatment to be made. However, few patients are capable of maneuvering through the medical 
information around their disease by themselves. Thus, medical information has to be provided 
in a way that is understandable, individualized and sufficient to make the patient capable of 
taking an active role in SDM, provided they want to. This study has aimed to investigate how 
patients’ verbal behavior might affect physician SDM behavior in medical consultations.  
For this study we chose to include newly admitted cancer patients with high information 
needs, with the knowledge that treatment decisions are often taken during their first 
consultations [17, 18]. Further, we hypothesized that if patients asked more questions it would 
affect physician SDM behavior. In a previous study, three specific questions concerning 
treatment options, their benefits and harms and the likelihood of these to happen, increased 
family physicians’ SDM behavior significantly. In this study the OPTION score increased 
from 25 to 36 [88]. Our study did not find a similar result. Even though the QPL increased the 
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number of questions concerning prognosis and optimal treatment, both important for SDM, 
providing patients with the QPL did not increase physician SDM.  
Patients’ expression of emotional cues and concerns along with physicians’ recognition of 
them appears to be related to the SDM process. In our study, approximately two third of the 
patients expressed one or more emotional cues and concerns during the consultation. The 
responses from the physicians were most often (78%) explicit and inviting. Empathy from 
physicians seems to affect patients’ desire for more information during the consultation [157]. 
Entwistle et al. [158] suggests that aims to support patient autonomy should include the 
patient-physician relationship as a facilitator. In general, the patient-physician relationship is 
identified as one key element in SDM [8, 159, 160]. In the OPTION 12 instrument, one of the 
twelve physician behaviors scored is how well physicians explore patients’ concerns about 
how the problem(s) are to be managed. Our study did not demonstrate any significant 
association between patients’ verbal behavior in form of emotional cues and concerns and 
physician SDM behavior, as measured by OPTION 12.  
The low OPTION scores in our study indicate that the physicians’ effort to engage their 
patients in SDM is scarce. The low level of physician SDM may also be affected by the type 
of treatment decisions in the consultations, patients’ desire to participate in SDM or 
challenges with the OPTION instrument.   
SDM is considered most relevant in situations when patients are faced with a preference 
sensitive decision, in which multiple treatment options with less clear evidence exists. Where 
patients have aggressive lymphoma, receiving intensive curative chemotherapy is likely to be 
a non-preference sensitive decision, considering the clear evidence of its effectiveness. 
However, few decisions in oncology comes with such a clear evidence. Choosing between 
life-extending treatments with limited response rates and potential side effects, or maximizing 
quality of life, is regarded as a highly preference sensitive decision. It is worth noting that 
even decisions with clear evidence can be preference sensitive, faced with patients divergent 
preferences or special clinical circumstances [72, 161].  
In this study, we had no data to suggest whether the treatment decisions are preference 
sensitive or not. As 25 % of patients were in a palliative setting, one could expect higher 
OPTION scores in these consultations, compared to the OPTION scores for consultations in a 
curative setting, but our analysis could not confirm this (unpublished data). 
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The Control Preference Scale (CPS) distinguishes between patients wanting an active, 
collaborative or passive role in decision making, and was used to address decision making 
preferences in our study. A meta-analysis of patient data from six clinical studies involving 
3491 US and Canadian cancer patients found that 26% wanted an active role, 49 % a 
collaborative role and 25% wanted a passive role in decision making [85]. Compared to our 
study, where 57 % stated they wanted a passive role, US and Canadian patients appears to 
want greater involvement in decision making that our patients. The results from our study are 
similar to findings in another Norwegian study of 60 cancer patients at time of diagnosis 
where only 8.3 % of patients wanted an active role, 29% preferred a collaborative role and 
62,7% wanted a passive role [87]. These results may indicate that Norwegian cancer patients 
have lower preference for participation in SDM. 
The OPTION 12 score assesses the physician SDM only and the low scores indicate that the 
physicians in our study performed poorly in the SDM process. The mean OPTION score in 
our study was 12.1 in the control group and 14.8 in the merged intervention groups. A 
systematic review of 29 studies using the OPTION 12 scale reported a mean OPTION score 
of 23 [78]. There are reasons to believe that although SDM now is a statutory patient right, it 
is a complicated task and not fully implemented in the health service [78, 162]  
The low OPTION score in our study could be due to a less preference sensitive nature of the 
decisions, few patients’ preferring to share decisions or physician poor SDM behavior. It 
could also be due to methodological weaknesses. 
There is no consensus in the literature on how to define the concept of SDM, and even less 
agreement on the most appropriate way to measure this behavior [163]. The OPTION 12 
instrument, which is an observer measure of SDM, is a one-dimensional scale, measuring 12 
items of physician SDM behavior [131].  It is the most frequently used observer measure of 
SDM and has previously been suggested as an efficient and sensitive coding system for SDM 
in oncology [164].  
Lately, the OPTION 12 instrument has received criticism due to several scale items that 
seldom are used, and especially for lacking focus on the different perspectives of SDM. In 
response to this criticism, the OPTION 5 instrument was created, which is better at 
differentiating between various levels of patient involvement and includes assessment of 
patient SDM behavior [165, 166]. A limitation of our study is that we only measured 
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physician SDM behavior, which might have impact on the ability to address other aspects of 
SDM. Makoul et al. [163] proposed a more integrative definition of SDM as a basis for 
describing and operationalization of elements of SDM. Caregivers were present in 
approximately one fourth of the consultations in our study, and in most consultations they 
were active participants and asked many questions. Although caregivers’ involvement in the 
SDM process was not assessed in our study, there are reasons to believe that their contribution 
in the SDM process is underestimated [167]. Caregivers’ involvement in the SDM process 
was not assessed in our study. It is possible that if we had used a SDM model in our study that 
accounted for the contribution of each participant in all elements of decision making during 
consultations, it could have provided our study with a different result [168].  
Previous research has found no correlation between observer and patients’ assessment of 
SDM in consultations [169]. In our study, we found a weak but significant association 
between the OPTION score and the patients’ judgment of their participation in SDM, as 
measured by CPS post consultation, R=.23 p=.046 (unpublished results). This correlation was 
so weak that it is reasonable to believe that the OPTION score and CPS post consultation 
accounts for different perspective of the concept.    
Given the increasing interest in SDM and the fact that it is required by law makes it even 
more important that we are able to measure to what extent patients actually are involved. 
SDM is a complex process and the current various SDM instruments measure only parts of 
the behavior. The fact that no existing instruments incorporates all elements and perspectives 
of SDM behavior is a challenge for SDM research. 
5.2 Methodological considerations 
5.2.1 Cultural adaptation of the QPL 
In this study, we obtained feedback from focus groups and a survey to adjust an existing 
Australian QPL to fit a Norwegian setting, as no standard method is described for cultural 
adaptation of QPLs. 
Our assumption was that Norwegian cancer patients might want to ask additional questions 
about topics that are not present in the Australian QPL, and that focus groups could identify 
potential missing questions. Consulting the target population by using focus groups is 
advocated as a good method for ensuring content validity [127]. While interviews can 
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enlighten the experiences and ideas of individuals, focus groups provide the added dimension 
of the interactions among members [170]. 
The recruitment process for the focus groups was not random. Participants were recruited 
through “Vardesenteret”, a support center for cancer patients and their caregivers, with 
posters presenting the study, and employees actively promoting the study to potential 
participants. This may have introduced a selection bias, which can occur in the process of 
identifying the study population, as one can assume that users of “Vardesenteret” differs from 
non-users [171]. In addition, employees might have been more likely to propose the study to 
certain users, to example those who were more outgoing or in better physical condition.  
On the other hand, purposeful sampling is a technique widely used in qualitative research for 
the identification and selection of information-rich cases for the most effective use of limited 
resources [172]. Purposive sampling can be valuable, as qualitative research usually aims to 
reflect the diversity within a given population [173] [174]. Given that “Vardesenteret” attracts 
people seeking interaction with other cancer patients/survivors, they might be more outgoing 
and likely to share their experiences in a focus group. 
The survey was conducted to test the generalizability of the results from the focus groups. The 
recruitment process for the survey was less exposed to selection bias, as all patients scheduled 
for an appointment at the cancer outpatient clinic at pre-specified days were invited.  
One of the strengths in our process of cultural adaptation of the QPL is the combination of 
focus groups and a survey, aiming to redress diversity and afterwards ensure the 
generalizability of findings. We believe that our combined methods approach may provide a 
useful model for future cultural adaptation of QPLs. 
5.2.2 The intervention study 
The gold standard when conducting clinical trials is a randomized control trial (RCT), which 
is proposed to provide the most reliable evidence about the effects of healthcare interventions 
[175]. Preferably, a RCT is designed to be double blinded to keep the allocation group hidden 
to both patient and investigator. Studies on communication are often less suitable for blinded 
trials as the intervention is often apparent to both patients and physicians. In addition, 
communication studies often target patients or physicians to behave differently, and thereby 
use the participants’ knowledge of the intervention as an intervention itself. 
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Our intervention study was conducted with a quasi-experimental design [176]. We chose to 
conduct an exploratory study with the entire control group preceding the two intervention 
groups. This was done to minimize any learning effect on physicians, as the intervention in 
itself could have encouraged physicians to behave differently to all patients in the study, 
including patients in the control group. 
The study was not blinded to neither patients nor physicians, as patients that received the QPL 
were encouraged to bring the QPL booklet to the consultation. To utilize the full effect of the 
QPL, the physicians were encouraged to address the QPL as early as possible in the 
consultation, and therefore the intervention could not be blinded to the physicians either. 
If more resources had been available for this study, a Patient Preference Trial (PPT), which 
accounts for patients’ treatment preferences, might have been a better model when exploring 
the use of communication aids [177]. While RCTs assume clinical equipoise, a PPT takes 
patients specific preference for (or against) the intervention into account [178]. Patients’ 
preferences may moderate intervention efficacy, especially where motivation can affect 
outcome, which might be the case with QPLs and CARs. 
5.3 Limitations 
We acknowledge that a limitation of this study is the small sample size, which can limit the 
possibility to detect a difference between groups, if a difference truly exists (type 2 error)  
[179]. Such error can be limited by sample size calculations to determine the right number of 
patients to include in the study. To do this one needs to have access to information of the 
study population. For this study, we had little data to help us determine the sample size, so we 
chose to use international numbers as a guide. After coding of the consultations, it was clear 
that we estimated a far too low standard deviation, compared to what was actually observed in 
the control group, which reduced our chance of detecting a difference between the groups 
regarding total question asking.  
The generalizability of study results largely depends upon whether the study population is 
representative of other population or not. This study was a single center study, and included 
only newly admitted patients that were well enough to attend outpatient consultations or focus 
groups. This makes it difficult to generalize the results to an inpatient setting, where patients 
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often receive treatment that is more aggressive or have poorer health, or to further 
consultations.  
In addition, the data from the group that received both the CAR and the QPL was insufficient 
to conclude on the added effect of a CAR on outcomes. At the time the second questionnaire 
was provided, only half of the patients had listened to the CAR, while most of the remaining 
patients stated they would or might listen to it later. To better identify outcomes affected by 
the CAR, the post consultation questionnaire should have been provided at a later stage to 
allow more patients to have experience with the use of the CAR.  
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6 CONCLUSION AND IMPLICATION FOR FURTHER 
RESEARCH 
Today, patient-centered care is recognized as a central element of high-quality health services 
and aims to provide care that is respectful and responsive to the individual patients’ 
preferences, needs and values. As a result, communication has become an essential 
component of the physicians’ role. While patients’ informational needs, emotional cues and 
concerns, and SDM are considered independently in the main discussion of the theses, they 
are all embraced in the concept of patient centered care. Prior research has shown an 
association between elements of communication and health outcomes, and there has been a 
growing interest to improve clinical communication, among other, by exploring the use of 
communication aids.  
This thesis presents the results of three studies in which we have developed a Norwegian 
QPL, and explored central elements of communication with or without introducing 
communication aids. During this work, we have investigated Norwegian cancer patients’ 
information need, the effect of providing patients with communication aids and physician 
SDM behavior in relation to patients’ verbal behavior and the provision of a QPL. 
In the first paper, we conclude that combining focus groups and a survey can be a useful 
method for adjusting QPLs to different cultural and organizational contexts. Further, there are 
reasons to believe that existing QPLs should be reviewed and revised regularly to retain their 
relevance. 
The audio recordings from the control group were subject to extended analyses in paper II. 
Patients in this part of the study were active asking questions, and we found that both 
questions and emotional cues and concerns were related to their anxiety level. Contrary to our 
hypothesis, we found no association between patients’ verbal behavior in form of question 
asking and expression of cues and concerns, and observed physician SDM as measured by 
OPTION.  
In the third paper, we found that providing patients with the QPL resulted in more questions 
concerning prognosis, the disease and quality of treatment, all which are important in SDM. 
This also resulted in a significantly longer consultation with their doctor. However, we did not 
find any relationship between the provision of a QPL and physician SDM. Both the QPL and 
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the CAR were rated positively by the patients in our study, yet we found no effect on patient 
outcomes or patients’ experience with the consultation. 
Our research has demonstrated the culturally adapted Norwegian QPL to broaden the range of 
questions asked by newly diagnosed cancer patients in an oncology outpatient setting. A QPL 
can easily be incorporated into regular doctor/patient interaction, provided in a pamphlet or 
website, while a CAR requires more technical resources. There are concerns that the increased 
consultation length can be an obstacle to implementing the QPL as standard of care. However, 
the study has highlighted aspects of clinical communication and communication aids and the 
challenges with outcome measures in communication research. Further QPL research should 
address the effect of the QPL on subsequent consultations and as part of communication 
studies involving both patient and physician interventions.  
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When you see your medical or radiation oncologist today 
you may have questions and concerns.  Often these 
are forgotten in the heat of the moment, only to be 
remembered later.  We have compiled a list of questions 
to help you to get the information you want from your 
oncologist about your illness, and possible treatments. 
These questions have been developed after discussion 
with many people.  Your oncologist is keen to answer 
any questions you may have, either now or at future 
consultations.  You and your family may choose to use this 
list at any time.  
We suggest you tick the questions that you want to ask 
and write down any that you may think of which are not 
listed.  In many cases, your oncologist will have answered the 
questions without you even asking, and in that instance this 
pamphlet can serve as a checklist.
HOW AND WHEN TO ASK QUESTIONS
❑ Do you have time today to discuss my questions?
❑ Can I ask you to explain any words that I am not   
 familiar with?
DIAGNOSIS
❑ What kind of cancer do I have?
❑ Where is the cancer at the moment? Has it spread to  
 other parts of my body?
❑ How common is my cancer?
TESTS
❑ Are there any further tests that I need to have?    
 What will they tell us?  Will they confi rm my diagnosis?
❑ What will I experience when having the test/s?
PROGNOSIS
❑ How bad is this cancer and what is it going to 
 mean for me? 
❑ What symptoms will the cancer cause?
❑ What is the aim of the treatment?  To cure the cancer or  
 to control it and manage symptoms?
❑ How likely is it that the cancer will spread to other parts  
 of my body without any more treatment?
 
❑ How likely is it that the cancer will spread to other parts  
 of my body if I do have more treatment?
❑ What is the expected survival for people with my 
 type of cancer?
❑ Is the treatment going to improve my chance of survival?
❑ How likely is it that the treatment will improve my   
 symptoms? Is it worth going through?
❑ Will the treatment or illness reduce my sexual drive?
OPTIMAL CARE
❑ Do you specialise in treating my type of cancer?
❑ How well established is the treatment you are   
 recommending?
❑ Are there guidelines on how to treat my cancer?
❑ Is there another specialist who treats this type of cancer   
 that you recommend for a second opinion?
THE MULTI-DISCIPLINARY TEAM
❑ Do you work in a multi-disciplinary team and what 
 does this mean?
❑ Can you explain the advantages of a team approach?
❑ How do you all communicate with each other and me?
❑ Who will be in charge of my care?
❑ What do I do if I get confl icting information?
TREATMENT INFORMATION AND OPTIONS
Options
❑ Is it necessary to have treatment right now?
❑ If so, do I have a choice of treatments?
❑ What are the pros and cons of each treatment option?
❑ What can I expect if I decide not to have treatment?
❑ How much time do I have to think about this?  Do you  
 need my decision today?
❑ What is your opinion about the best treatment for me?
Treatment
❑ What exactly will be done during the treatment and how 
 will it affect me? When are these effects likely to happen?
❑ What is the treatment schedule, e.g. how many   
 treatments will I have, how often, and for how long 
 will I have treatment?
❑ Where will I have the treatment?
❑ Are there any advantages/disadvantages of the private  
 versus public health system?
Clinical Trials
❑ What are clinical trials? Are there any that might be  
 relevant for me?
❑ Will I be treated any differently if I enrol in a trial?
Preparing for Treatment
❑ Is there anything that I can do before or after my   
 treatment that might make it more effective, e.g. diet,  
 work, exercise, etc?
❑ What are the do’s and don’ts while having treatment? 
❑ What problems should I look out for and who do I  
 contact if they occur?
❑ Are there long-term side effects from the treatment?
❑ Will I need any additional treatment after this? If so, what  
 might that be?
❑ What is my long-term follow up plan?
Costs
❑ What will be the costs throughout my treatment,  
 e.g. medication, chemotherapy, etc?
❑ Am I eligible for any benefi ts if I cannot work?
Support Information
❑ What information is available about my cancer and its  
 treatment, e.g. books, videos, websites, etc?
❑ Are there any complementary therapies that you believe  
 may be helpful or that are known to be bad for me?
❑ Is there someone I can talk to who has been through 
 this treatment?
❑ Are there services/support groups that can help me and  
 my family deal with this illness?
 









Kvalitet Trygghet Respekt Omsorg
Når du møter din kreftlege kan du ha spørsmål og bekymringer. 
For å hjelpe deg å få den informasjonen du ønsker om sykdommen og mulige 
behandlinger har vi satt sammen en liste med spørsmål du kanskje ønsker 
svar på. Dette er spørsmål som har blitt utviklet etter diskusjon med mange 
mennesker som har/har hatt kreft eller jobber med kreft. Spørsmålene er 
generelle og ikke alle spørsmål trenger å være relevante for deg. 
Din kreftlege ønsker å svare på spørsmål du måtte ha, enten nå eller i 
fremtidige konsultasjoner. Ta gjerne denne lista med til første 
konsultasjon, men du og din familie kan velge å bruke lista når som helst.
Vi foreslår at du haker av spørsmålene du ønsker å spørre og skriver ned de 
spørsmålene du har som ikke omfattes av lista. Vi vet at det er lett å glemme å 
ta opp spørsmål/bekymringer under legetimen, for så å huske på dem i etter-
kant. I mange tilfeller vil legen besvare spørsmålene dine uten at du trenger å 
spørre,  i så tilfelle kan lista tjene som en sjekkliste.
Mine spørsmål
Når og hvordan man kan stille spørsmål
Diagnose
Undersøkelser
Har du tid til å svare på noen spørsmål i dag?
Kan du forklare noen ord jeg ikke forstår?
Hvilken type kreft har jeg?
Hvor finnes det kreftceller akkurat nå? 
Har kreften spredd seg til andre deler av kroppen min?
Hvor vanlig er den typen kreft jeg har?
Trenger jeg å ta flere undersøkelser/prøver? Hva vil disse kunne vise? Vil 
de kunne bekrefte diagnosen jeg har fått?
Hva går denne/disse undersøkelsen(e) ut på?
Prognose
Hvor alvorlig er den krefttypen jeg har, og hva betyr det for meg?
Hvilke plager kan jeg få som følge av kreftsykdommen?
Er det vanlig å oppleve smerter ved min type kreftsykdom og hvor kan 
jeg eventuelt få hjelp til å lindre smerter?
Hva er målet med behandlingen? Å kurere kreftsykdommen eller holde 
den i sjakk og lindre plager?
Hvor sannsynlig er det at kreftsykdommen vil spre seg til andre deler av 
kroppen dersom jeg ikke får mer behandling?
Hvor sannsynlig er det at kreftsykdommen vil spre seg til andre deler av 
kroppen om jeg får videre behandling?
Hvor mange med min type kreft blir friske?
Vil behandlingen øke min sjanse for å bli frisk?
Hvor sannsynlig er det at behandlingen vil lindre mine plager? Er det verd 
å forsøke den?
Vil behandlingen eller sykdommen påvirke seksuallivet mitt?
Behandling
Kan du forklare meg nøyaktig hva det er som skjer under behandlingen, 
og hvordan dette kan påvirke meg? Når vil jeg mest sannsynlig merke 
dette?
Hvordan er behandlingsplanen, f.eks. hvor mange behandlinger skal jeg 
ha, hvor ofte og hvor lenge vil jeg få behandling?
Hvor vil jeg få behandlingen? 
Optimal behandling
Har du/dere erfaring med å behandle min type kreft?
Hvor godt utprøvd er den behandlingen du anbefaler?
Finnes det retningslinjer for hvordan min type kreft bør behandles?
Finnes det et annet sykehus hvor jeg kan be om en ny vurdering?
Tverrfaglig team
Er min behandling  diskutert i et tverrfaglig møte?
Hvordan kommuniserer dere med hverandre, fastlegen og med meg?
Hvem har ansvaret for min behandling?
Hva gjør jeg om jeg får motstridende informasjon/opplysninger?
Valgmuligheter
Er det nødvendig at jeg starter behandling nå?
Finnes det i så fall ulike behandlinger å velge mellom?
Hva er fordelene og ulempene med de ulike behandlingene?
Hva kan skje hvis jeg velger å ikke få behandling?
Hvor lang tid har jeg til å tenke over dette? Må jeg bestemme meg i dag?
Hva mener du er den beste behandlingen for meg?




Hvilke ekstra utgifter kan jeg forvente som følge av kreftsykdommen?
Vil jeg ha krav på ytelser dersom jeg ikke kan jobbe?
Er det greit at jeg har med pårørende på samtalen? Vil de få dekket 
utgifter til reise og opphold?
Finnes det tjenester/støttegrupper som kan hjelpe meg og min familie 
med å takle sykdommen?
Hvordan bør jeg informere mine barn om kreftsykdommen? Hvor kan jeg 
eventuelt få råd eller hjelp til dette?
Hva slags informasjon er tilgjengelig om min kreftsykdom og 
behandlingen, f.eks brosjyrer, nettsider eller bøker?
Finnes det alternativ/komplementær behandling som du mener kan 
hjelpe meg, eller som man vet kan være skadelig for meg?




Er det noe jeg selv kan gjøre før eller etter behandling som kan gjøre 
behandlingen mer effektiv, f.eks. når det gjelder kosthold, arbeid, 
trening?
Hva kan jeg gjøre, og hva bør jeg ikke gjøre i behandlingsperioden?
Hvilke bivirkninger bør jeg være oppmerksom på, og hvem tar jeg 
kontakt med dersom de oppstår?
Har behandlingen noen langsiktige bivirkninger/seneffekter?
Når vil livet normaliseres igjen? Finnes det rehabiliteringstilbud for kreft-
pasienter?
Vil jeg trenge videre behandling etter dette? Hvis ja, hvilken type 
behandling er det snakk om?












FOKUSGRUPPE INTERVJU GUIDE 
 TANKER OM SPØRSMÅL TIL DISKUSJON 09.04.2014  
”KOMMUNIKASJON MELLOM PASIENT OG LEGE PÅ KREFT POLIKLINIKK”    
 
Introduksjon til fokusgruppen  
- Takk for at dere har sagt ja til å delta 
- Presentasjon av forskere – de ulike rollene  
o Anita  
o Bente  
 
-   Presentasjon ved navn deltakere  
 
 
FOKUS I INTERVJUET - HVA ER HENSIKTEN  
- Skjemaet utviklet i Australia for australske forhold – oversatt og tatt i bruk i andre land/ Italia  
- Vi vet at det er noen kulturelle forskjeller mellom landene OG noen forskjeller i hvordan 
helsevesenet er organisert 
 
- NÅ ønsker å ta dette i bruk i Norge og tilpasse det til norske forhold  
 
- Så lengt som mulig sikre at det er godt tilpasset norske forhold og norske kreftpasienters 
behov  
 
- Grunnstammen i skjemaet er der allerede – men ønsker innspill, tanker og hjelp fra dere ift.   
 
1) Er dette relevante spørsmål for norske kreftpasienter?  
2) Er det noe annet som burde være med, noe dere ser noen mangler?  
3) ( ---- (evt noe som skal bort/ er irrelevant)) 
 
Samlet dere som gruppe fordi har et felles utgangspunkt i = erfaringer med å være kreftsyk OG 
erfaringer fra møter i poliklinikken  
Tas opp på bånd …  
Spørre om noen har spørsmål til den skriftlige/muntlige informasjonen om FOKUSGRUPPENE  






PRAKTISK GJENNOMFØRING  
Mange spørsmål – som vi har delt opp i litt større bolker – som naturlig hører sammen 
Jeg leser opp spørsmålene i hver bolk SÅ diskuterer dere/vi spørsmålene i hver bolk for seg i forhold 
til:  
1) Ser/høres det greit ut sånn som det står nå?  
2) Er det noe som mangler – noe annet som burde vært med?  
 
-Språklig forståelig  
-Noe irrelevant  
-Mange spørsmål  
 
OPPSUMMERE  
Når vi nå har gått gjennom alle spørsmålene:   
1) Helhetlig – er det noe som mangler når man nå lager en norsk oversettelse eller utgave? 
2) Er det noen spørsmål som dere tenker – opplever som ubehagelig å spørre om?  
 
 
 
 
 
 
 
 
 
